Drug intelligence / Profile preview

АДП-М-Біолік

Development stage
Unknown
Lead developer
Farmstandart-Biolik
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

АДП-М-Біолік (ADP-M-Biolik) is an adsorbed, reduced-dose diphtheria-tetanus (Td) vaccine manufactured by Biolik Biopharmaceutical in Ukraine. It contains purified concentrated diphtheria toxoid (5 Lf) and purified concentrated tetanus toxoid (5 binding units) adsorbed onto an aluminum-based adjuvant. The vaccine is indicated for preventive immunization against diphtheria and tetanus, specifically for routine booster vaccinations in adolescents aged 16 years and adults every 10 years, as well as for primary immunization of previously unvaccinated children from 7 years of age and adults. It works by inducing the formation of specific active immunity through the production of neutralizing antibodies against the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*. This formulation is characterized by its reduced antigen content compared to standard pediatric formulations, making it suitable for booster doses in older populations.

Brand names
АДП-М-БіолікADP-M-Biolik
Other names
АДП-М-БІОЛІКADP-M-Biolik
02

Targets

Diphtheria toxin

Beyond the preview

Go deeper on АДП-М-Біолік.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on АДП-М-Біолік.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call